Загрузка...

Precision Bioactives & Peptide Signaling: The Next Frontier in Clinical Longevity

AMP + Healthgevity Presents: Precision Bioactives & Peptide Signaling: The Next Frontier in Clinical Longevity

On May 20, 2026, Michael Antonelli, CEO of Healthgevity joined Accelerated Medical Practices and shared the “Precision Bioactives & Peptide Signaling: The Next Frontier in Clinical Longevity.” This presentation offered a forward-looking perspective on how emerging bioactive compounds and peptide signaling systems are reshaping the way we approach metabolic health, inflammation, and aging at the molecular level. It was designed for leading clinicians, this discussion will bridge cutting-edge science with real-world application—highlighting a new paradigm in personalized, systems-based care.

Видео Precision Bioactives & Peptide Signaling: The Next Frontier in Clinical Longevity канала Accelerated Medical Practices
Яндекс.Метрика
Все заметки Новая заметка Страницу в заметки
Страницу в закладки Мои закладки
На информационно-развлекательном портале SALDA.WS применяются cookie-файлы. Нажимая кнопку Принять, вы подтверждаете свое согласие на их использование.
О CookiesНапомнить позжеПринять